Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 11, 2007, Pages 4459-4466

  Yin, Ping ^a   Lin, Zhihong ^a   Cheng, You Hong ^a   Marsh, Erica E ^a   Utsunomiya, Hiroki ^a   Ishikawa, Hiroshi ^a   Xue, Qing ^a   Reierstad, Scott ^a   Innes, Joy ^a   Thung, Stephen ^b   Kim, J Julie ^a   Xu, Eugene ^a   Bulun, Serdar E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR MODULATOR; PROMEGESTONE; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; UTERUS BLEEDING; UTERUS MYOMA;

EID: 35948971359     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0725     Document Type: Article

References (40)

1. Chwalisz K, Perez MC, Demanno D, Winkel C, Schubert G, Elger W 2005 Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr Rev 26:423-438
2. Kovacs KA, Lengyel F, Kornyei JL, Vertes Z, Szabo I, Sumegi B, Vertes M 2003 Differential expression of Akt/protein kinase B, Bcl-2 and Bax proteins in human leiomyoma and myometrium. J Steroid Biochem Mol Biol 87:233-240
3. Brandon DD, Bethea CL, Strawn EY, Novy MJ, Burry KA, Harrington MS, Erickson TE, Warner C, Keenan EJ, Clinton GM 1993 Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol 169:78-85
4. Kawaguchi K, Fujii S, Konishi I, Nanbu Y, Nonogaki H, Mori T 1989 Mitotic activity in uterine leiomyomas during the menstrual cycle. Am J Obstet Gynecol 160:637-641
5. Tiltman AJ 1985 The effect of progestins on the mitotic activity of uterine fibromyomas. Int J Gynecol Pathol 4:89-96
6. Matsuo H, Maruo T, Samoto T 1997 Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone. J Clin Endocrinol Metab 82:293-299
7. Maruo T, Matsuo H, Shimomura Y, Kurachi O, Gao Z, Nakago S, Yamada T, Chen W, Wang J 2003 Effects of progesterone on growth factor expression in human uterine leiomyoma. Steroids 68:817-824
8. Chegini N, Ma C, Tang XM, Williams RS 2002 Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression. Mol Hum Reprod 8:1071-1078
9. Xu Q, Takekida S, Ohara N, Chen W, Sitruk-Ware R, Johansson ED, Maruo T 2005 Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5′-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells. J Clin Endocrinol Metab 90:953-961
10. Chen W, Ohara N, Wang J, Xu Q, Liu J, Morikawa A, Sasaki H, Yoshida S, Demanno DA, Chwalisz K, Maruo T 2006 A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells. J Clin Endocrinol Metab 91:1296-1304
11. Sasaki H, Ohara N, Xu Q, Wang J, DeManno DA, Chwalisz K, Yoshida S, Maruo T 2007 A novel selective progesterone receptor modulator asoprisnil activates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated signaling pathway in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells. J Clin Endocrinol Metab 92:616-623
12. Friedman AJ, Daly M, Juneau-Norcross M, Rein MS, Fine C, Gleason R, Leboff M 1993 A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri. J Clin Endocrinol Metab 76:1439-1445
13. Fiscella K, Eisinger SH, Meldrum S, Feng C, Fisher SG, Guzick DS 2006 Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial. Obstet Gynecol 108:1381-1387
14. Chwalisz K, DeManno D, Garg R, Larsen L, Mattia-Goldberg C, Stickler T 2004 Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata. Semin Reprod Med 22:113-119
15. Tsujimoto Y, Erikson J, Nowell PC, Croce CM 1986 Molecular genetics of human B cell neoplasia. Symp Fundam Cancer Res 38:79-93
16. Korsmeyer SJ 1992 Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80:879-886
17. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ 1990 Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602-3610
18. Kandouz M, Siromachkova M, Jacob D, Chretien Marquet B, Therwath A, Gompel A 1996 Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells. Int J Cancer 68:120-125
19. Gompel A, Sabourin JC, Martin A, Yaneva H, Audouin J, Decroix Y, Poitout P 1994 Bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol 144:1195-1202
20. Jeong JW, Lee KY, Kwak I, White LD, Hilsenbeck SG, Lydon JP, DeMayo FJ 2005 Identification of murine uterine genes regulated in a ligand-dependent manner by the progesterone receptor. Endocrinology 146:3490-3505
21. Rossi MJ, Chegini N, Masterson BJ 1992 Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro. Endocrinology 130:1716-1727
22. Deb S, Zhou J, Amin SA, Imir AG, Yilmaz MB, Lin Z, Bulun SE 2006 A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts. J Biol Chem 281:2585-2597
23. Kobayashi S, Lackey T, Huang Y, Bisping E, Pu WT, Boxer LM, Liang Q 2006 Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB J 20:800-802
24. Heckman CA, Mehew JW, Ying GG, Introna M, Golay J, Boxer LM 2000 A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells. J Biol Chem 275:6499-6508
25. Kastner P, Bocquel MT, Turcotte B, Garnier JM, Horwitz KB, Chambon P, Gronemeyer H 1990 Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms. J Biol Chem 265:12163-12167
26. Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai MJ, O'Malley BW 1999 The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol 19:1182-1189
27. Zaitseva M, Vollenhoven BJ, Rogers PA 2006 In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells. Mol Hum Reprod 12:187-207
28. Tang XM, Rossi MJ, Masterson BJ, Chegini N 1994 Insulin-like growth factor I (IGF-I), IGF-I receptors, and IGF binding proteins 1-4 in human uterine tissue: tissue localization and IGF-I action in endometrial stromal and myometrial smooth muscle cells in vitro. Biol Reprod 50:1113-1125
29. Lieberman BA, Bona BJ, Edwards DP, Nordeen SK 1993 The constitution of a progesterone response element. Mol Endocrinol 7:515-527
30. Shyamala G 1997 Roles of estrogen and progesterone in normal mammary gland development. Insights from progesterone receptor null mutant mice and in situ localization of receptor. Trends Endocrinol Metab 8:34-39
31. Bulun S, Adashi E 2003 The physiology and pathology of the female reproduction axis. In: Larson PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams textbook of endocrinology. Chap 16. Philadelphia: Elsevier Science USA; 587-664
32. Kumar NS, Richer J, Owen G, Litman E, Horwitz KB, Leslie KK 1998 Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action. Cancer Res 58:1860-1865
33. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM 2000 Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289:1751-1754
34. Conneely OM, Mulac-Jericevic B, DeMayo F, Lydon JP, O'Malley BW 2002 Reproductive functions of progesterone receptors. Recent Prog Horm Res 57:339-355
35. Beato M, Herrlich P, Schutz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857
36. Beato M 1989 Gene regulation by steroid hormones. Cell 56:335-344
37. Scheidereit C, Westphal HM, Carlson C, Bosshard H, Beato M 1986 Molecular model of the interaction between the glucocorticoid receptor and the regulatory elements of inducible genes. DNA 5:383-391
38. Tsai SY, Carlstedt-Duke J, Weigel NL, Dahlman K, Gustafsson JA, Tsai MJ, O'Malley BW 1988 Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell 55:361-369
39. Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler PB 1991 Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352:497-505
40. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT, Edwards DP 2001 Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 8:269-280